Model DetailsErythrocyte hyperplasia(Spleen)
Model Name |
Erythrocyte hyperplasia (Spleen) | Strain |
BALB/cStCrlfC3Hf/Nctr |
Tumor Inducing Agent(s) |
None (spontaneous) |
Tumor Synonyms |
erythroid hyerplastic lesion • splenic erythropoietic hyperplasia • erythropoiesis "in excess of normal limits" • erythropoiesis of spleen |
Strain Synonyms |
BALB/cStCrlfC3HJ/Nctr • BALB/cStCrlfC3H/Nctr • BALB/cStcrlfC3Hf/Nctr • BALB/c |
| Organ Affected | Sex | Frequency | Age Of Detection | Additional Information Expand all Collapse all | Reference |
|---|---|---|---|---|---|
| Spleen | Male |
5.3% (8 of 152 mice) |
21-141 days |
|
Frith CH, Lab Anim Sci 1983 Jun;33(3):273-86 |
| Spleen | Male |
0.9% (1 of 110 mice) |
142-318 days |
|
Frith CH, Lab Anim Sci 1983 Jun;33(3):273-86 |
| Spleen | Male |
2.1% (5 of 236 mice) |
319-500 days |
|
Frith CH, Lab Anim Sci 1983 Jun;33(3):273-86 |
| Spleen | Male |
2.1% (4 of 188 mice) |
>500 days |
|
Frith CH, Lab Anim Sci 1983 Jun;33(3):273-86 |
| Spleen | Male |
1.3% (1 of 76 mice) |
319-500 days |
|
Frith CH, Lab Anim Sci 1983 Jun;33(3):273-86 |
| Spleen | Male |
6.8% (4 of 59 mice) |
>500 days |
|
Frith CH, Lab Anim Sci 1983 Jun;33(3):273-86 |
| Spleen | Female |
1.0% (2 of 192 mice) |
21-141 days |
|
Frith CH, Lab Anim Sci 1983 Jun;33(3):273-86 |
| Spleen | Female |
0% (0 of 99 mice) |
142-318 days |
|
Frith CH, Lab Anim Sci 1983 Jun;33(3):273-86 |
| Spleen | Female |
0.4% (1 of 239 mice) |
319-500 days |
|
Frith CH, Lab Anim Sci 1983 Jun;33(3):273-86 |
| Spleen | Female |
3.2% (7 of 222 mice) |
>500 days |
|
Frith CH, Lab Anim Sci 1983 Jun;33(3):273-86 |
| Spleen | Female |
4.5% (7 of 155 mice) |
319-500 days |
|
Frith CH, Lab Anim Sci 1983 Jun;33(3):273-86 |
| Spleen | Female |
4.0% (5 of 126 mice) |
>500 days |
|
Frith CH, Lab Anim Sci 1983 Jun;33(3):273-86 |
| Spleen | Male |
1.2% (11 of 953 mice) |
<6 months |
|
Frith CH, J Gerontol 1981 Sep;36(5):534-45 |
| Spleen | Female |
0.37% (4 of 1072 mice) |
<6 months |
|
Frith CH, J Gerontol 1981 Sep;36(5):534-45 |
| Spleen | Male |
3.1% (8 of 258 mice) |
6-12 months |
|
Frith CH, J Gerontol 1981 Sep;36(5):534-45 |
| Spleen | Female |
2.1% (15 of 705 mice) |
6-12 months |
|
Frith CH, J Gerontol 1981 Sep;36(5):534-45 |
| Spleen | Male |
2.3% (8 of 353 mice) |
12-18 months |
|
Frith CH, J Gerontol 1981 Sep;36(5):534-45 |
| Spleen | Female |
5.0% (80 of 1609 mice) |
12-18 months |
|
Frith CH, J Gerontol 1981 Sep;36(5):534-45 |
| Spleen | Male |
4.2% (12 of 287 mice) |
>18 months |
|
Frith CH, J Gerontol 1981 Sep;36(5):534-45 |
| Spleen | Female |
8.3% (198 of 2374 mice) |
>18 months |
|
Frith CH, J Gerontol 1981 Sep;36(5):534-45 |